wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39020641-C33F7EE2-3A87-405D-9593-5E4C74333DAA
Q39020641-C33F7EE2-3A87-405D-9593-5E4C74333DAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39020641-C33F7EE2-3A87-405D-9593-5E4C74333DAA
Promising Novel Agents for Aggressive B-Cell Lymphoma.
P2860
Q39020641-C33F7EE2-3A87-405D-9593-5E4C74333DAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39020641-C33F7EE2-3A87-405D-9593-5E4C74333DAA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d338ce32e613938029498dabdbfeeb4e0d020a39
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies